Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study (OSEBERG)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Sykehuset i Vestfold HF
Sponsor:
Information provided by (Responsible Party):
Dag Hofsø, Sykehuset i Vestfold HF
ClinicalTrials.gov Identifier:
NCT01778738
First received: December 3, 2012
Last updated: May 3, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2023
  Estimated Primary Completion Date: December 2022 (Final data collection date for primary outcome measure)